These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 33650079)

  • 1. Deciphering the roles of glycogen synthase kinase 3 (GSK3) in the treatment of autism spectrum disorder and related syndromes.
    Rizk M; Saker Z; Harati H; Fares Y; Bahmad HF; Nabha S
    Mol Biol Rep; 2021 Mar; 48(3):2669-2686. PubMed ID: 33650079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging pharmacological therapies in fragile X syndrome and autism.
    Yamasue H; Aran A; Berry-Kravis E
    Curr Opin Neurol; 2019 Aug; 32(4):635-640. PubMed ID: 31045620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting age related changes in autism spectrum disorder phenomenology in Cornelia de Lange, Fragile X, and Cri du Chat syndromes: Results from a 2.5 year follow-up.
    Cochran L; Moss J; Nelson L; Oliver C
    Am J Med Genet C Semin Med Genet; 2015 Jun; 169(2):188-97. PubMed ID: 25989416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models.
    Kosillo P; Bateup HS
    Front Neural Circuits; 2021; 15():700968. PubMed ID: 34366796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate-mediated signaling and autism spectrum disorders: emerging treatment targets.
    Yang P; Chang CL
    Curr Pharm Des; 2014; 20(32):5186-93. PubMed ID: 24410563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The psychopharmacology of autism spectrum disorder and Rett syndrome.
    Persico AM; Ricciardello A; Cucinotta F
    Handb Clin Neurol; 2019; 165():391-414. PubMed ID: 31727226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin as a Novel Interventional Candidate for Fragile X Syndrome with Autism Spectrum Disorder in Humans.
    Won J; Jin Y; Choi J; Park S; Lee TH; Lee SR; Chang KT; Hong Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28632163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological and ASD phenotypes in rare genetic syndromes: A critical review of the literature.
    Bush L; Scott MN
    Clin Neuropsychol; 2022 Jul; 36(5):993-1027. PubMed ID: 34569897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of GABAergic neural circuits in the pathogenesis of autism spectrum disorder.
    Di J; Li J; O'Hara B; Alberts I; Xiong L; Li J; Li X
    Int J Dev Neurosci; 2020 Apr; 80(2):73-85. PubMed ID: 31910289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of autistic spectrum disorder with insulin-like growth factors.
    Riikonen R
    Eur J Paediatr Neurol; 2016 Nov; 20(6):816-823. PubMed ID: 27562096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal control of translation and transcription in autism spectrum disorder.
    Longo F; Klann E
    EMBO Rep; 2021 Jun; 22(6):e52110. PubMed ID: 33977633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of the Main Genetic, Epigenetic and Environmental Factors Involved in Autism Spectrum Disorder Focusing on Synaptic Activity.
    Masini E; Loi E; Vega-Benedetti AF; Carta M; Doneddu G; Fadda R; Zavattari P
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental divergence: motor trajectories in children with fragile X syndrome with and without co-occurring autism.
    Will EA; Bishop SL; Roberts JE
    J Neurodev Disord; 2019 Oct; 11(1):23. PubMed ID: 31586494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function.
    Gilbert J; O'Connor M; Templet S; Moghaddam M; Di Via Ioschpe A; Sinclair A; Zhu LQ; Xu W; Man HY
    J Neurosci; 2020 Jan; 40(1):237-254. PubMed ID: 31704787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The autism spectrum phenotype in ADNP syndrome.
    Arnett AB; Rhoads CL; Hoekzema K; Turner TN; Gerdts J; Wallace AS; Bedrosian-Sermone S; Eichler EE; Bernier RA
    Autism Res; 2018 Sep; 11(9):1300-1310. PubMed ID: 30107084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Akt-mTOR pathway rescued the social behavior in Cntnap2-deficient mice.
    Xing X; Zhang J; Wu K; Cao B; Li X; Jiang F; Hu Z; Xia K; Li JD
    Sci Rep; 2019 Feb; 9(1):3041. PubMed ID: 30816216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders.
    Benachenhou S; Laroui A; Dionne O; Rojas D; Toupin A; Çaku A
    Int Rev Neurobiol; 2023; 173():115-139. PubMed ID: 37993175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Report: Autism Symptoms in Infants with Fragile X Syndrome.
    Roberts JE; Tonnsen BL; McCary LM; Caravella KE; Shinkareva SV
    J Autism Dev Disord; 2016 Dec; 46(12):3830-3837. PubMed ID: 27628938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mTOR, a Potential Target to Treat Autism Spectrum Disorder.
    Sato A
    CNS Neurol Disord Drug Targets; 2016; 15(5):533-43. PubMed ID: 27071790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autism Symptoms in Fragile X Syndrome.
    Niu M; Han Y; Dy ABC; Du J; Jin H; Qin J; Zhang J; Li Q; Hagerman RJ
    J Child Neurol; 2017 Sep; 32(10):903-909. PubMed ID: 28617074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.